|
Sign In to gain access to subscriptions and/or personal tools.
|
Differences in blood activation related to roller/centrifugal pumps and heparin coated/uncoated surfaces in a cardiopulmonary bypass model circuit
O. Moen
Department of Cardiothoracic Surgery and Institute for Experimental Medical Research, Uilevaal Hospital
E. Fosse
Department of Cardiothoracic Surgery, Ullevaål Hospital, Oslo
J. Bråten
Department of Cardiothoracic Surgery, Ullevaål Hospital, Oslo
C. Andersson
Department of Cardiothoracic Surgery, Ullevaål Hospital, Oslo
K. Høgåsen
Institute for Immunology and Rheumatology, The National Hospital, University of Oslo, Oslo
TE Mollnes
Institute for Immunology and Transfusion Medicine, Nordland Central Hospital, Universitv of Tromsø, Tromso
P. Venge
Institute for Clinical Chemistry, University of Uppsala, Uppsala
P. Kierulf
Institute for Clinical Chemistry, Ullevaål Hospital, Oslo
An in vitro model cardiopulmonary bypass (CPB) circuit consisting ot tubing, oxygenator and venous reservoirs with either a roller or a centrifugal pump, and with either heparin-coated (Carmeda Bioactive Surface, CBAS) or uncoated surfaces, was studied with respect to 'blood activation', using small- scale-based blood volume (450 + 500 ml). Sixteen circuits were tested in each pump group, eight with and eight without heparin-coated surfaces, by circulating heparinized fresh human blood for 72 hours at 30°C. Blood plasma, sampled at defined intervals, was analysed for haemolysis (lactate dehydrogenase and potassium), complement activation (C3bc and C5b-9 (TCC)), complement lytic inhibitors (vitronectin and clusterin), coagulation activation (fibrinopeptide A), granulocyte (lactoferrin and myeloperoxidase) and platelet (ß-thromboglobulin) activation and contaminating endotoxin. The heparin coating significantly reduced the concentrations of C3bc, TCC, fibrinopeptide A, lactoferrin, myeloperoxidase and ß-thromboglobulin. The two pump types did not differ with respect to these parameters, but the roller pump caused significantly higher increases in plasma LDH and potassium and significantly greater reductions in clusterin and vitronectin than the centrifugal pump. Endotoxin concentration was low at the start and after 24 hours in all groups. These results confirm that heparin-coated CPB surfaces reduce blood activation, and suggest that centrifugal pumps cause less haemolysis and less reduction in lytic complement inhibitors than roller pumps.
Perfusion, Vol. 11, No. 2,
113-123 (1996)
DOI: 10.1177/026765919601100205

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. W. Hammon
Extracorporeal Circulation: Perfusion System
Card. Surg. Adult,
January 1, 2008;
3(2008):
350 - 370.
[Full Text]
|
 |
|

|
 |

|
 |
 
The Society of Thoracic Surgeons Blood Conservatio, V. A. Ferraris, S. P. Ferraris, S. P. Saha, E. A. Hessel II, C. K. Haan, B. D. Royston, C. R. Bridges, R. S.D. Higgins, G. Despotis, et al.
Perioperative Blood Transfusion and Blood Conservation in Cardiac Surgery: The Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists Clinical Practice Guideline
Ann. Thorac. Surg.,
May 1, 2007;
83(5_Supplement):
S27 - S86.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Jensen, S. Andreasson, A. Bengtsson, H. Berggren, R. Ekroth, L. E. Larsson, and J. Ouchterlony
Changes in hemostasis during pediatric heart surgery: impact of a biocompatible heparin-coated perfusion system
Ann. Thorac. Surg.,
March 1, 2004;
77(3):
962 - 967.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Jensen, S. Andreasson, A. Bengtsson, H. Berggren, R. Ekroth, L. Lindholm, and J. Ouchterlony
Influence of two different perfusion systems on inflammatory response in pediatric heart surgery
Ann. Thorac. Surg.,
March 1, 2003;
75(3):
919 - 925.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. A. Hessel II and L. H. Edmunds Jr.
Extracorporeal Circulation: Perfusion Systems
Card. Surg. Adult,
January 1, 2003;
2(2003):
317 - 338.
[Full Text]
|
 |
|

|
 |

|
 |
 
J. B Zwischenberger and S. K Alpard
Artificial lungs: a new inspiration
Perfusion,
July 1, 2002;
17(4):
253 - 268.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Scholz, R. Solberg, C. Okkenhaug, V. Videm, M. J Gallimore, O. Mathisen, T. E Mollnes, A. Bergan, O. Soreide, G. B Klintmalm, et al.
The significance of heparin-coated veno-venous bypass circuits in liver transplantation
Perfusion,
January 1, 2002;
17(1):
45 - 50.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Parolari, F. Alamanni, M. Naliato, R. Spirito, V. Franze, G. Pompilio, M. Agrifoglio, and P. Biglioli
Adult cardiac surgery outcomes: role of the pump type
Eur. J. Cardiothorac. Surg.,
November 1, 2000;
18(5):
575 - 582.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Weerasinghe and K. M. Taylor
The platelet in cardiopulmonary bypass
Ann. Thorac. Surg.,
December 1, 1998;
66(6):
2145 - 2152.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M G Macey, D A McCarthy, U H Trivedi, G E Venn, D J Chambers, and K A Brown
Neutrophil adhesion molecule expression during cardiopulmonary bypass: a comparative study of roller and centrifugal pumps
Perfusion,
September 1, 1997;
12(5):
293 - 301.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
H E Hogevold, O Moen, E Fosse, P Venge, J Braten, C Andersson, and T Lyberg
Effects of heparin coating on the expression of CD11b, CD11c and CD62L by leucocytes in extracorporeal circulation in vitro
Perfusion,
January 1, 1997;
12(1):
9 - 20.
[Abstract]
[PDF]
|
 |
|
|
|